Bini, C., A. Marcellusi, F. S. Mennini, S. Ripoli, L. Fioravanti, V. F. Paly, A. Molinari, P. Morelli, S. Krotneva, and S. Li. “Cost-Effectiveness of Brentuximab Vedotin Plus Chemotherapy As Frontline Treatment of Stage IV Hodgkin Lymphoma in Italy”. Global and Regional Health Technology Assessment, vol. 11, no. 1, Dec. 2024, pp. 248-57, doi:10.33393/grhta.2024.3167.